Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR

Journal of Virological Methods

Volumn 117, Issue 2, 2004, Pages 179-187

  Schalk, Johanna A C ^a   Van Den Elzen, Christa ^a   Ovelgönne, Hans ^a   Baas, Chantal ^a   Jongen, Peter M J M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Measles vaccine; Potency assay; Quantitative real time PCR

Indexed keywords

LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; TRIPLE VACCINE;

ACCURACY; ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; DILUTION; DRUG POTENCY; MEASLES VIRUS; NONHUMAN; PARALLEL DESIGN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TECHNIQUE; VALIDATION PROCESS; VERO CELL; VIRUS DETECTION; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CERCOPITHECUS AETHIOPS; MEASLES VACCINE; MEASLES VIRUS; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VERO CELLS; VIRUS REPLICATION;

MEASLES VIRUS;

EID: 1642355874     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.01.009     Document Type: Article

References (10)

1. Van Binnendijk R.S., van den Hof S., van den Kerkhof H., Kohl R.H.G., Woonink F., Berbers G.A.M., Conyn-van Spaendonck M.A.E., Kimman T.G. Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands. J. Infect. Dis. 188:2003;898-903.
2. Davis, B.D., Dulbecco, R., Eisen, H.N., Ginsberg, H.S., 1990. Microbiology, fourth ed. J.B. Lippincott Company, Philadelphia, pp. 787-794.
3. European Pharmacopoeia, 2002. Fourth ed. Directorate for the Quality of Medicines of the Council of Europe (EDQM), Strasbourg, France.
4. Forsey T., Heath A.B., Minor P.D. A collaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines. Biologicals. 20:1992;233-234.
5. Forsey T., Heath A.B., Minor P.D. A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines. Biologicals. 21:1993;239-249.
6. Fukuda A., Hishiyama M., Umino Y., Suiura A. Immunocytochemical focus assay for potency determination of measles-mumps-rubella-trivalent vaccine. J. Virol. Methods. 15:1987;279-284.
7. Fukuda A., Sengün F., Sarpay H.E., Konobe T., Saito S., Umino Y., Kohama T. Parameters for plaque formation in potency assay of Japanese measles vaccines. J. Virol. Methods. 61:1996;1-6.
8. Lewis, J.A., Ranheim, T.S., Wang, F., Moyer, P., Smith, M.E., Benz, R., Mathis, W.C., Schofield, T.L., Hager, A., 2001. Novel use of Q-PCR technology to assay the potency of live virus vaccines. Symposium Abstract. Well Characterized Biological Products, 5th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products.
9. Olsewski, L., 2001. Infectivity PCR: an alternative for viral clearance and inactivation studies. http://www.pda.org/public%20presentations/2001PDA-FDA- viralagenda.html.
10. Sastry L., Johnson T., Hobson M.J., Smucker B., Cornetta K. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9:2002;1155-1162.